Sai Life Sciences Limited, a key player in the pharmaceutical sector, is gearing up for its ₹3,042.62 crore Initial Public Offering (IPO). The offering comprises a fresh issue of ₹950 crores and an Offer for Sale (OFS) of ₹2,092.62 crores. The company is known for its expertise in research and small-molecule new chemical entity research …

